FromAstraZeneca ([email protected])
Subject (135)Alexion data presented at EAN 2025 highlights its leadership and commitment to improving patient outcomes in rare neurological diseases
Preheader (135)Alexion data presented at EAN 2025 highlights its leadership and commitment to improving patient outcomes in rare neurological diseases
Arial
Text Analysis
Body Words128
Subject Words19
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px716 px
X-Spam Score-2.0
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening
